Subscribe
aga7ta-shutterstock-com
aga7ta / Shutterstock.com
8 February 2016Americas

Federal Circuit revives catheter patents dispute

The US Court of Appeals for the Federal Circuit has revived medical device company TriReme Medical’s attempt to correct the record of three patents related to catheters.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Inventor wins $1.2m from Medcomp and Martech over infringed catheter device
18 January 2021   Sister medical device companies, Medical Components and Martech Medical Products, are liable for $1.2 million after a federal court in Pennsylvania ruled that both infringed a patent covering the design of a handle on a medical device.


Editor's picks

LSPN: In-house ‘chess game’ is the same, but the rules have changed
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

Editor's picks

Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Americas
Inventor wins $1.2m from Medcomp and Martech over infringed catheter device
18 January 2021   Sister medical device companies, Medical Components and Martech Medical Products, are liable for $1.2 million after a federal court in Pennsylvania ruled that both infringed a patent covering the design of a handle on a medical device.

More on this story

Americas
Inventor wins $1.2m from Medcomp and Martech over infringed catheter device
18 January 2021   Sister medical device companies, Medical Components and Martech Medical Products, are liable for $1.2 million after a federal court in Pennsylvania ruled that both infringed a patent covering the design of a handle on a medical device.

More features

LSPN: In-house ‘chess game’ is the same, but the rules have changed
Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims